Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 3,600 shares, an increase of 300.0% from the February 13th total of 900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Santhera Pharmaceuticals Stock Performance

OTCMKTS:SPHDF opened at $16.00 on Thursday. The company’s fifty day moving average price is $9.68 and its 200-day moving average price is $10.66. Santhera Pharmaceuticals has a 1-year low of $9.42 and a 1-year high of $16.00.

About Santhera Pharmaceuticals

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).